Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Dennis Fenton


  • Director at Anaptysbio Inc (ANAB), 2020-02-13
  • Director at Portola Pharmaceuticals Inc (PTLA), 2019-06-17
  • at Sienna Biopharmaceuticals Inc. (SNNA), 2019-06-03
  • Director at Pfenex Inc. (PFNX), 2017-05-08
  • Director at Xenoport Inc (XNPT), 2016-07-07
  • Director at Kythera Biopharmaceuticals Inc (KYTH), 2015-10-02
  • Director at Hospira Inc (HSP), 2015-09-03
  • Director at Dendreon Corp (DNDN), 2014-01-07
  • Director at Genzyme Corp (GENZ), 2011-04-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SNNA $22.96 1,250 Director 1,250 2017-09-18 Filing
XNPT $4.02 3,000 Director 13,000 2014-05-27 Filing
XNPT $7.86 300 Director 1,300 2010-11-12 Filing
XNPT $7.87 35 Director 1,000 2010-11-12 Filing
XNPT $7.92 100 Director 965 2010-11-12 Filing